GTBPbenzinga

What's Going On With GT Biopharma Stock Tuesday?

Summary

GT Biopharma entered into a definitive securities purchase agreement for the purchase and sale of 740,000 shares of its common stock at a purchase price of $4.35 per share. The shares will be offered in a registered direct offering priced at-the-market under Nasdaq rules.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 21, 2024 by benzinga